Analysis · Exor N.V.
Exor: a factory for sale, exit costs still to negotiate
The proposed Brampton sale highlights a Stellantis challenge: resizing its industrial footprint without exit costs consuming the expected benefit.
Courtesy translation of the French original.
A factory that no longer produces still raises a practical question: who pays for what comes next? In Brampton, Canada, Stellantis is seeking a future for a plant where retooling is suspended. On 11 September 2026, the carmaker confirmed a memorandum of understanding with Canadian armoured-vehicle manufacturer Roshel concerning a possible sale. Neither a price nor a definitive agreement has been announced.
For Exor shareholders, this is about more than Canadian property. Stellantis, the group behind Peugeot, Citroën, Fiat and Jeep among other brands, is a substantial holding: Exor owns 15.5% of its economic rights. At the published end-2025 reference point, the stake was worth approximately €4.3 billion, or 11.5% of Exor's gross asset value. Gross asset value adds up investments before deducting holding-company debt; it is not net asset value. These are not updated September market values.

An industrial possibility, a labour disagreement
Roshel offers the prospect of a different use for the site. Through its spokesperson quoted by Canadian Press, Stellantis presents the proposal as a route towards sustainable operations. That is the carmaker's position, not yet a completed transaction's outcome.
Meanwhile, Unifor has announced a pause in collective bargaining, placing Brampton's future at the centre of the disagreement. The current agreement expires on 20 September. The pause establishes neither a strike nor a definitive breakdown in negotiations.
Brampton
A sale could end some site costs. Its price and retained commitments remain unknown.
Stellantis
Any proceeds must be considered alongside exit costs, labour obligations and industrial consequences.
Exor
The effect runs through Stellantis's value and distributions. Exor does not automatically receive 15.5% of the plant's sale price.
What matters is what remains after the exit
Opulion's reading is straightforward: selling a site can release tied-up capital and reduce future expenditure. But compensation, transition investment or disruption could make the economic benefit very different from the headline price. These are items to investigate, not costs already quantified in this case.
For Exor, the announcement warrants focused monitoring: a definitive agreement, remaining obligations, the outcome of negotiations and the financial effect reported by Stellantis. Translating the memorandum into a gain in Exor's net asset value would be premature. A possible exit has appeared; its cost remains unknown.
Sources
- Exor, Stellantis ownership and portfolio weight
- Exor, 2025 results and portfolio reference date, 23 March 2026
- Canadian Press via CHCH, Stellantis statement on Roshel, 11 September 2026
- Unifor, statement on Stellantis negotiations, 11 September 2026
- Stellantis, Brampton Assembly Plant history, updated April 2026
Share